InvestorsHub Logo
icon url

vdb_123

09/01/18 9:28 PM

#23778 RE: chilling #23777

yeah, if you compare with TLRY or Canopy or CRON it seems possible. I was thinking $50 by sometime next year if they make some progress on Phase I trial, NASDAQ listing and CBD sales ~$75m -$90m. Will be happy to see if it happens before that.
icon url

ANIA77

09/01/18 11:00 PM

#23785 RE: chilling #23777

Yes, TLRY valuation is sick imo. I think it is a classic case of market high demand. People are more and more interested in MJ stocks and there is really only few of them on Nasdaq. CVSI is going to be very very attractive imo. Outstanding growth QoQ, excellent margin, profitable, and absolutely Zero debt... hello??? If this doesn't sound like no brainer buy, then I don't know what is.
$CVSI